HPLC-MS/MS based Cytochrome P450 2E1 (CYP2E1) Inhibition Assessment Service
Our HPLC-MS/MS-based Cytochrome P450 2E1 (CYP2E1) Inhibition Assessment Service provides comprehensive analysis for evaluating the inhibitory effects of compounds on CYP2E1. Using state-of-the-art technology and expertise, we offer accurate and reliable results to help you understand the potential for drug-drug interactions and assess the safety and efficacy of new drug candidates.
HPLC-MS/MS-based CYP Inhibition Assessment Platform
HPLC-MS/MS-based Cytochrome P450 2E1 (CYP2E1) Inhibition Assessment Service
CYP2E1
CYP2E1 is a member of the cytochrome P450 enzyme family, which is responsible for metabolizing a wide range of substances in the body. CYP2E1 plays a role in the metabolism of various compounds, as well as in the breakdown of alcohol in the liver. It is also involved in the activation of certain carcinogens, making it a potential target for drug development and cancer research. Dysregulation of CYP2E1 activity has been linked to various diseases, including liver damage, alcohol-induced liver disease, and certain types of cancer.
What We Do
Our HPLC-MS/MS-based CYP2E1 inhibition assessment service provides accurate and reliable measurement of CYP2E1 inhibition by test compounds. Our experienced team of scientists will work closely with you to design custom assay protocols and deliver high-quality data to support your drug discovery and development programs. This service includes:
- HPLC separation of test compounds and metabolites
- MS/MS detection and quantification of CYP2E1 activity and metabolite formation
- Determination of IC50 values for test compounds to assess their inhibitory effects on CYP2E1 activity
Detailed Information of Our Service
- CYP2E1 Information
| Protein Name | Family | Sub Family | Uniprot Number | Gene Name |
| CYP2E1 | CYP450 | CYP2 | P05181 | CYP2E1 |
| Gene ID | Gene Aliases | Organism | Construct Details | Tissue |
| 1571 | CYPIIE1 | Human | Microsomes | Liver |
- Assay Information
Service Type
Biochemical
Function Mode
Antagonist
Measured Response
Peak Area Response
Service Sub Type
Enzymatic
Detection Method
HPLC-MS/MS
Substrate
Chlorzoxazone
Advantages of Our Service
HPLC-MS/MS-based Cytochrome P450 2E1 (CYP2E1) inhibition assessment offers several advantages over traditional methods such as spectrophotometric or fluorometric assays:
- Increased Sensitivity
HPLC-MS/MS is a highly sensitive technique that can accurately measure small changes in enzyme activity.
- Specificity
HPLC-MS/MS allows for the specific detection and quantification of CYP2E1 inhibition in complex biological samples, minimizing interference from other compounds.
- High Throughput
HPLC-MS/MS is a fast and efficient technique that can analyze multiple samples simultaneously, leading to increased throughput and reduced experimental time.
- Quantitative Analysis
HPLC-MS/MS provides accurate and precise quantification of CYP2E1 inhibition, allowing for the determination of IC50 values and other important parameters.
- Stability
HPLC-MS/MS is a robust and reproducible method, providing consistent results over time and between different laboratories.
- Compatibility with Various Substrates
HPLC-MS/MS can be used with a wide range of substrates, allowing for the assessment of CYP2E1 inhibition with different compounds.
Cooperation With Creative Biolabs
Frequently Asked Question
A1: Why do CYP2E1 inhibition assessment?
Q1:
- Drug development: CYP2E1 inhibition assessment is important in drug development to understand the potential for drug-drug interactions and to predict the metabolism of new drugs.
- Toxicity evaluation: CYP2E1 is involved in the metabolism of many toxic substances, so assessing its inhibition can provide important information about the potential toxicity of a compound.
- Environmental exposure assessment: CYP2E1 is also involved in the metabolism of environmental toxins, so assessing its inhibition can help evaluate the potential impact of exposure to these substances.
- Disease research: CYP2E1 plays a role in the metabolism of various drugs and toxic compounds, so assessing its inhibition can provide insights into the mechanisms underlying certain diseases.
Contact Us
To learn more about our HPLC-MS/MS-based CYP2E1 Inhibition Assessment Service or to discuss your specific needs, please contact us now. Our team of experts is ready to assist you with any questions or inquiries you may have. Let us help you advance your research and drug development efforts with our reliable and efficient service. In addition to this service, we also offer:
Small-Molecule Drug Bioanalysis Service
Large-Molecule Drug Bioanalysis Service
LC-MS-based Bioanalysis Service
Download our brochure